Tesamorelin (5mg)
For Research Use Only. Not for human consumption.
99%+ purity
$69.00 – $590.00
Buy Tesamorelin online from Tetrava Labs. Tesamorelin is a stabilized GHRH analogue researched for visceral adipose and GH-axis metabolic endpoint models.
- FREE shipping on all orders
- Guaranteed delivery to your doorstep
- Secure payment with card or crypto
- Enjoy discounts with every purchase
24/7 support — Email or WhatsApp
Select strength
1 / 5 / 10 vials
$590.00
$690.00
10 vials · $59.00/vial
You save $100
What is Tesamorelin?
Tesamorelin is a stabilized growth-hormone-releasing hormone analog. Clinical trials have explored a branded form in HIV-associated visceral fat redistribution. That labeled use does not attach to a research vial.[1]
Tetrava Labs sells tesamorelin as Research Use Only research peptides. A tesamorelin peptide buy or buy tesamorelin online order here is a reagent purchase, not Egrifta. Not for human or veterinary use.
Tesamorelin Peptide Research
What tesamorelin is
Tesamorelin is a GHRH analog. It occupies the GHRH receptor and, in clinical research, moves the downstream GH axis.[1] It is not 191-amino-acid growth hormone. It is not a ghrelin-receptor secretagogue.
The prescription product is sold as Egrifta for a labeled population. The lyophilized research listing is a different commercial object even when the amino-acid story overlaps.
GHRH receptor vs ghrelin receptor
GHRH analogs and GHS-R1a ligands can both raise GH in research models. They do it through different receptors.[2] Tesamorelin is on the GHRH side. Ipamorelin is on the ghrelin-mimetic side.
A GHRH-receptor cAMP or reporter plate wants tesamorelin. A GHS-R1a binding plate does not. Secretagogue reviews are background. They are not tesamorelin methods.[2]
The labeled indication stays with the drug
The 2007 NEJM trial scored metabolic effects of a growth-hormone-releasing factor in patients with HIV-associated fat redistribution.[1] That dataset belongs to a developed product.
Tesamorelin peptide where to buy is a reagent search. Treating the FDA-facing indication as a property of catalog powder is how the aims paragraph goes wrong.
VAT endpoints do not belong on a cAMP plate
Falutz used visceral adipose tissue and related metabolic laboratories as clinical endpoints.[1] If your plate is a GHRH-receptor cAMP assay harvested at 30 minutes versus 4 hours, keep those endpoints.
A 30-minute read can catch an early cyclase peak. A 4-hour read can catch desensitization or media exhaustion. Neither time point is a body-composition study.
Tesamorelin vs ipamorelin
Ipamorelin is the ghrelin-mimetic comparison in this catalog. Sermorelin is the shorter GHRH(1-29) comparison. All three sit in the growth-hormone-axis file. None of them is somatropin.[2]
Tetrava lists tesamorelin in 5 mg, 10 mg, and 20 mg lyophilized vials. Tesamorelin 10mg for sale is a mass on a label. Check that mass against the lot-linked HPLC identity in the Certificate of Analysis.
What Falutz actually scored
The NEJM paper's endpoints were visceral adipose tissue and related metabolic laboratories in patients with HIV-associated fat redistribution, not a GHRH-receptor reporter harvested at 30 minutes.[1] Keep the imaging endpoint in the trial and the cyclase endpoint on the plate. They do not convert. The 20 mg catalog vial is still a fill mass. It is not a larger Egrifta carton.
Storage and lot notes
Store sealed lyophilized vials per your peptide SOP. File the lot COA with the material ID so the RUO analog is not confused with a branded drug record in the ELN.
References & Citations
Author Profile
Tetrava Labs Editorial Team
Editorial Team, Tetrava Labs
Content published by Tetrava Labs is compiled and fact-checked using peer-reviewed scientific literature, HPLC-MS Certificates of Analysis (COA), and primary biochemical data. Research use only.
Frequently Asked Questions
Research Use Only Disclaimer
All products are intended for laboratory research purposes only. Not approved for human consumption, diagnostic use, or therapeutic applications. By purchasing, you confirm you are a qualified research professional.
